申请人:Bangalore Ramesh
公开号:US20100209537A1
公开(公告)日:2010-08-19
This inventive subject matter relates to novel transitional metal complexes of Quinoxalines, methods for making such compounds, and methods for using such compounds for treating diseases and disorders mediated by kinase activity.
The present invention relates to new substituted Quinoxaline compounds, their tautomers, stereoisomers, polymorphs, esters, metabolites, and prodrugs, to the pharmaceutically acceptable salts of the compounds, tautomers, stereoisomers, polymorphs, esters, metabolites, and prodrugs, to compositions of any of the aforementioned embodiments together with pharmaceutically acceptable carriers, and to uses of any of the aforementioned embodiments, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of cancer.
本发明涉及新型喹喔啉过渡金属配合物、制备这些化合物的方法,以及使用这些化合物治疗由激酶活性介导的疾病和疾病的方法。本发明涉及新的取代喹喔啉化合物、它们的互变异构体、立体异构体、多晶形、酯类、代谢物和前药,以及这些化合物、互变异构体、立体异构体、多晶形、酯类、代谢物和前药的药学上可接受的盐,任何上述实施例的组合物与药学上可接受的载体,以及任何上述实施例的用途,无论是单独使用还是与至少一种其他治疗剂联合使用,在预防或治疗癌症方面。